A look at the state of insulin affordability in 2020 and how the ongoing pandemic has impacted the situation.
The affordability of insulin is a constant topic of discussion for diabetics and their care providers. While the cost of medication was already an issue for many diabetic patients, it has been further compounded by the ongoing coronavirus disease 2019 (COVID-19) pandemic.
In the following interview, Diana Isaacs, PharmD, a clinical pharmacist and diabetes care and education specialist at the Cleveland Clinic, discusses the affordability of insulin and how the ability of patients to afford their medications has been impacted by the pandemic. A leader in her field, Isaacs offers perspective on topics from how to approach these delicate conversations with patients to the best resources for patients who may be struggling to afford their insulin.